95 results
Page 3 of 5
8-K
EX-99.1
f4tzrek07v4vp
1 Feb 12
AspenBio Sets 2012 AppyScore Anticipated Milestones; Sees Pivotal Clinical Trial for Appendicitis Test Beginning Mid-2012
12:00am
8-K
EX-99.1
iq4in37
28 Dec 11
AspenBio Announces Registered Direct Offering of Approximately $1.6 Million
12:00am
8-K
EX-99.1
v1ynf8qs y28j
29 Nov 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.2
ubi572ei23i cqex
29 Nov 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.1
alz5psgw 84eh
31 Oct 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.2
bh9mcqob
31 Oct 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.1
e3q3i z2o8z
20 Oct 11
AspenBio Reports Interim Data from AppyScore Pilot Study and Outlook for Regulatory Pathway
12:00am
8-K
EX-99.1
rldoxo9j32ur rbdfoal
21 Jul 11
Other Events
12:00am
8-K
EX-99.1
4fgzy7
19 Jul 11
Other Events
12:00am
8-K
rdmc 1bg2lz18
10 Jan 11
Regulation FD Disclosure
12:00am
8-K
EX-99.1
y58lh7mecq3skbqw7m
20 Jul 10
AspenBio Pharma Reports AppyScore™ ELISA-based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-based Test
12:00am
8-K
EX-99.1
2c50v nwijkr
7 Jun 10
AspenBio Pharma Updates on AppyScore™ FDA 510(k) Filing and Data Analysis
12:00am
424B5
c4wzrcj3w6put9jwjp
30 Apr 10
Prospectus supplement for primary offering
12:00am